Financial Metrics

CAH CARDINAL HEALTH INC

Range: 2016-01-01 to 2026-04-29

Export Quarterly CSV Export Annual CSV

Chart Range:

% Change:

Annual View:

Financial Statements

Grouped by statement

Income Statement

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	1.17	—	USD/shares	10-Q	2016-05-03
Quarterly	2018-09-30	1.94	+65.8%	USD/shares	10-Q	2019-11-07
Quarterly	2019-09-30	-16.65	-958.2%	USD/shares	10-Q	2020-11-05
Quarterly	2020-09-30	-0.86	+94.8%	USD/shares	10-Q	2021-11-09
Quarterly	2021-09-30	0.94	+209.3%	USD/shares	10-Q	2022-11-04
Quarterly	2022-09-30	0.4	-57.4%	USD/shares	10-Q	2023-11-03
Quarterly	2023-09-30	-0.05	-112.5%	USD/shares	10-Q	2024-11-01
Quarterly	2024-09-30	1.7	+3500.0%	USD/shares	10-Q	2025-10-30
Quarterly	2025-09-30	1.88	+10.6%	USD/shares	10-Q	2025-10-30
Annual	2016-06-30	4.32	—	USD/shares	10-K	2018-08-22
Annual	2017-06-30	4.03	-6.7%	USD/shares	10-K	2019-08-20
Annual	2018-06-30	0.81	-79.9%	USD/shares	10-K	2020-08-13
Annual	2019-06-30	4.53	+459.3%	USD/shares	10-K	2021-08-16
Annual	2020-06-30	-12.61	-378.4%	USD/shares	10-K	2022-08-11
Annual	2021-06-30	2.08	+116.5%	USD/shares	10-K	2023-08-15
Annual	2022-12-31	-0.3	-114.4%	USD/shares	10-K	2024-08-14
Annual	2023-12-31	1.5	+600.0%	USD/shares	10-K	2024-08-14
Annual	2024-06-30	3.45	+130.0%	USD/shares	10-K	2025-08-12
Annual	2025-06-30	6.45	+87.0%	USD/shares	10-K	2025-08-12

Balance Sheet

Frequency	Period End	Value	% Chg	Unit	Form	Filed

Cash Flow

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	284000000.0	—	USD	10-Q	2017-05-02
Quarterly	2016-09-30	100000000.0	-64.8%	USD	10-Q	2017-11-07
Quarterly	2016-12-31	213000000.0	+113.0%	USD	10-Q	2018-02-08
Quarterly	2017-03-31	293000000.0	+37.6%	USD	10-Q	2018-05-09
Quarterly	2017-09-30	67000000.0	-77.1%	USD	10-Q	2018-11-08
Quarterly	2017-12-31	168000000.0	+150.7%	USD	10-Q	2019-02-07
Quarterly	2018-03-31	246000000.0	+46.4%	USD	10-Q	2019-05-09
Quarterly	2018-09-30	58000000.0	-76.4%	USD	10-Q	2019-11-07
Quarterly	2018-12-31	116000000.0	+100.0%	USD	10-Q	2020-02-06
Quarterly	2019-03-31	192000000.0	+65.5%	USD	10-Q	2020-05-11
Quarterly	2019-09-30	72000000.0	-62.5%	USD	10-Q	2020-11-05
Quarterly	2019-12-31	149000000.0	+106.9%	USD	10-Q	2021-02-05
Quarterly	2020-03-31	239000000.0	+60.4%	USD	10-Q	2021-05-06
Quarterly	2020-09-30	78000000.0	-67.4%	USD	10-Q	2021-11-09
Quarterly	2020-12-31	174000000.0	+123.1%	USD	10-Q	2022-02-03
Quarterly	2021-03-31	274000000.0	+57.5%	USD	10-Q	2022-05-05
Quarterly	2021-09-30	67000000.0	-75.5%	USD	10-Q	2022-11-04
Quarterly	2021-12-31	141000000.0	+110.4%	USD	10-Q	2023-02-02
Quarterly	2022-03-31	223000000.0	+58.2%	USD	10-Q	2023-05-04
Quarterly	2022-09-30	70000000.0	-68.6%	USD	10-Q	2023-11-03
Quarterly	2022-12-31	155000000.0	+121.4%	USD	10-Q	2024-02-01
Quarterly	2023-03-31	264000000.0	+70.3%	USD	10-Q	2024-05-02
Quarterly	2023-09-30	92000000.0	-65.2%	USD	10-Q	2024-11-01
Quarterly	2023-12-31	206000000.0	+123.9%	USD	10-Q	2025-01-30
Quarterly	2024-03-31	318000000.0	+54.4%	USD	10-Q	2025-05-01
Quarterly	2024-09-30	90000000.0	-71.7%	USD	10-Q	2025-10-30
Quarterly	2024-12-31	189000000.0	+110.0%	USD	10-Q	2026-02-05
Quarterly	2025-03-31	315000000.0	+66.7%	USD	10-Q	2025-05-01
Quarterly	2025-09-30	108000000.0	-65.7%	USD	10-Q	2025-10-30
Quarterly	2025-12-31	239000000.0	+121.3%	USD	10-Q	2026-02-05
Annual	2016-06-30	465000000.0	—	USD	10-K	2018-08-22
Annual	2017-06-30	387000000.0	-16.8%	USD	10-K	2019-08-20
Annual	2018-06-30	384000000.0	-0.8%	USD	10-K	2020-08-13
Annual	2019-06-30	328000000.0	-14.6%	USD	10-K	2021-08-16
Annual	2020-06-30	375000000.0	+14.3%	USD	10-K	2022-08-11
Annual	2021-06-30	400000000.0	+6.7%	USD	10-K	2023-08-15
Annual	2022-06-30	387000000.0	-3.2%	USD	10-K	2024-08-14
Annual	2023-06-30	481000000.0	+24.3%	USD	10-K	2025-08-12
Annual	2024-06-30	511000000.0	+6.2%	USD	10-K	2025-08-12
Annual	2025-06-30	547000000.0	+7.0%	USD	10-K	2025-08-12

Share Data

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	331000000.0	—	shares	10-Q	2017-05-02
Quarterly	2016-09-30	322000000.0	-2.7%	shares	10-Q	2017-11-07
Quarterly	2016-12-31	319000000.0	-0.9%	shares	10-Q	2018-02-08
Quarterly	2017-03-31	318000000.0	-0.3%	shares	10-Q	2018-05-09
Quarterly	2017-09-30	318000000.0	+0.0%	shares	10-Q	2018-11-08
Quarterly	2017-12-31	316000000.0	-0.6%	shares	10-Q	2019-02-07
Quarterly	2018-03-31	315000000.0	-0.3%	shares	10-Q	2019-05-09
Quarterly	2018-09-30	306000000.0	-2.9%	shares	10-Q	2019-11-07
Quarterly	2018-12-31	300000000.0	-2.0%	shares	10-Q	2020-02-06
Quarterly	2019-03-31	299000000.0	-0.3%	shares	10-Q	2020-05-11
Quarterly	2019-09-30	296000000.0	-1.0%	shares	10-Q	2020-11-05
Quarterly	2019-12-31	294000000.0	-0.7%	shares	10-Q	2021-02-05
Quarterly	2020-03-31	294000000.0	+0.0%	shares	10-Q	2021-05-06
Quarterly	2020-09-30	293000000.0	-0.3%	shares	10-Q	2021-11-09
Quarterly	2020-12-31	295000000.0	+0.7%	shares	10-Q	2022-02-03
Quarterly	2021-03-31	294000000.0	-0.3%	shares	10-Q	2022-05-05
Quarterly	2021-09-30	289000000.0	-1.7%	shares	10-Q	2022-11-04
Quarterly	2021-12-31	281000000.0	-2.8%	shares	10-Q	2023-02-02
Quarterly	2022-03-31	275000000.0	-2.1%	shares	10-Q	2023-05-04
Quarterly	2022-09-30	273000000.0	-0.7%	shares	10-Q	2023-11-03
Quarterly	2022-12-31	261000000.0	-4.4%	shares	10-Q	2024-02-01
Quarterly	2023-03-31	258000000.0	-1.1%	shares	10-Q	2024-05-02
Quarterly	2023-09-30	249000000.0	-3.5%	shares	10-Q	2024-11-01
Quarterly	2023-12-31	246000000.0	-1.2%	shares	10-Q	2025-01-30
Quarterly	2024-03-31	245000000.0	-0.4%	shares	10-Q	2025-05-01
Quarterly	2024-09-30	245000000.0	+0.0%	shares	10-Q	2025-10-30
Quarterly	2024-12-31	243000000.0	-0.8%	shares	10-Q	2026-02-05
Quarterly	2025-03-31	241000000.0	-0.8%	shares	10-Q	2025-05-01
Quarterly	2025-09-30	239000000.0	-0.8%	shares	10-Q	2025-10-30
Quarterly	2025-12-31	237000000.0	-0.8%	shares	10-Q	2026-02-05
Annual	2016-06-30	330000000.0	—	shares	10-K	2018-08-22
Annual	2017-06-30	320000000.0	-3.0%	shares	10-K	2019-08-20
Annual	2018-06-30	315000000.0	-1.6%	shares	10-K	2020-08-13
Annual	2019-06-30	301000000.0	-4.4%	shares	10-K	2021-08-16
Annual	2020-06-30	293000000.0	-2.7%	shares	10-K	2022-08-11
Annual	2021-06-30	294000000.0	+0.3%	shares	10-K	2023-08-15
Annual	2022-06-30	279000000.0	-5.1%	shares	10-K	2024-08-14
Annual	2023-06-30	262000000.0	-6.1%	shares	10-K	2025-08-12
Annual	2024-06-30	247000000.0	-5.7%	shares	10-K	2025-08-12
Annual	2025-06-30	242000000.0	-2.0%	shares	10-K	2025-08-12

Credit and Bond Coverage

Company-level

Long-Term Debt (latest annual)

N/A

Total Liabilities (latest annual)

N/A

Current Liabilities (latest annual)

38,897,000,000

Metrics

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.0574	—	ratio	10-Q	2017-05-02
Quarterly	2016-09-30	0.0475	-17.2%	ratio	10-Q	2017-11-07
Quarterly	2016-12-31	0.0511	+7.6%	ratio	10-Q	2018-02-08
Quarterly	2017-03-31	0.0573	+12.2%	ratio	10-Q	2018-05-09
Quarterly	2017-09-30	0.0175	-69.5%	ratio	10-Q	2018-11-08
Quarterly	2017-12-31	0.1382	+690.9%	ratio	10-Q	2019-02-07
Quarterly	2018-03-31	0.0338	-75.5%	ratio	10-Q	2019-05-09
Quarterly	2018-09-30	0.1005	+197.0%	ratio	10-Q	2019-11-07
Quarterly	2018-12-31	0.0465	-53.7%	ratio	10-Q	2020-02-06
Quarterly	2019-03-31	0.0475	+2.1%	ratio	10-Q	2020-05-11
Quarterly	2019-09-30	-5.4496	-11573.6%	ratio	10-Q	2020-11-05
Quarterly	2019-12-31	0.2196	+104.0%	ratio	10-Q	2021-02-05
Quarterly	2020-03-31	0.2910	+32.6%	ratio	10-Q	2021-05-06
Quarterly	2020-09-30	-0.1775	-161.0%	ratio	10-Q	2021-11-09
Quarterly	2020-12-31	0.3190	+279.7%	ratio	10-Q	2022-02-03
Quarterly	2021-03-31	0.0669	-79.0%	ratio	10-Q	2022-05-05
Quarterly	2021-09-30	0.1948	+191.3%	ratio	10-Q	2022-11-04
Quarterly	2021-12-31	0.0489	-74.9%	ratio	10-Q	2023-02-02
Quarterly	2022-03-31	2.0058	+4001.6%	ratio	10-Q	2023-05-04
Quarterly	2022-09-30	-0.0624	-103.1%	ratio	10-Q	2023-11-03
Quarterly	2022-12-31	0.0588	+194.2%	ratio	10-Q	2024-02-01
Quarterly	2023-03-31	-0.1564	-366.2%	ratio	10-Q	2024-05-02
Quarterly	2023-09-30	0.0030	+101.9%	ratio	10-Q	2024-11-01
Quarterly	2023-12-31	-0.1040	-3511.3%	ratio	10-Q	2025-01-30
Quarterly	2024-03-31	-0.0780	+25.0%	ratio	10-Q	2025-05-01
Quarterly	2024-09-30	-0.1273	-63.2%	ratio	10-Q	2025-10-30
Quarterly	2024-12-31	-0.1373	-7.9%	ratio	10-Q	2026-02-05
Quarterly	2025-03-31	-0.2677	-95.0%	ratio	10-Q	2025-05-01
Quarterly	2025-09-30	-0.1662	+37.9%	ratio	10-Q	2025-10-30
Quarterly	2025-12-31	-0.1744	-4.9%	ratio	10-Q	2026-02-05
Annual	2020-06-30	-2.0608	—	ratio	10-K	2022-08-11
Annual	2021-06-30	0.3771	+118.3%	ratio	10-K	2023-08-15
Annual	2024-06-30	-0.2656	-170.4%	ratio	10-K	2025-08-12
Annual	2025-06-30	-0.5957	-124.3%	ratio	10-K	2025-08-12

8-K Material Event Details

64 filings · 164 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

217 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value X-axis date:

All Transactions

Date	Insider	Title	Type	Security	Shares	Price	Total Value	Post-Tx Shares
2026-02-27	Greene Michelle D.	Chief Information Officer	Open-market sell S	Common Shares	2,646	$228.47	$604,532	12,230
2026-02-27	Greene Michelle D.	Chief Information Officer	Open-market sell S	Common Shares	100	$228.55	$22,855	14,876
2026-02-18	Alt Aaron E	Chief Financial Officer	Open-market sell S	Common Shares	2,328	$225.50	$524,964	26,408
2026-02-15	Alt Aaron E	Chief Financial Officer	Other disposed transaction F	Common Shares	1,914	$220.79	$422,592	28,736
2026-02-06	Hall Patricia Hemingway	Dir	Open-market sell S	Common Shares	4,000	$229.72	$918,880	28,264
2026-01-15	Pitteroff Valerie Christine	Chief Human Resources Officer	Equity grant / award A	Common Shares	3,982	$213.26	$849,201	8,022
2025-12-01	Mayer Jessica L	Chief Legal/Compliance Officer	Other disposed transaction F	Common Shares	422	$212.26	$89,574	34,427
2025-11-05	Ramakrishna Sudhakar	Dir	Equity grant / award A	Common Shares	1,067	$0.00	$0	2,116
2025-08-20	WEITZMAN DEBORAH	CEO, PSS Segment	Open-market sell S	Common Shares	21,367	$150.53	$3,216,375	53,428
2025-08-19	Scherer Mary C.	Chief Accounting Officer	Open-market sell S	Common Shares	6,766	$149.25	$1,009,826	3,556
2025-08-15	Scherer Mary C.	Chief Accounting Officer	Other disposed transaction F	Common Shares	2,572	$150.22	$386,366	10,322
2025-08-15	Scherer Mary C.	Chief Accounting Officer	Equity grant / award A	Common Shares	1,203	$0.00	$0	12,894
2025-08-12	Greene Michelle D.	Chief Information Officer	Equity grant / award A	Common Shares	16,362	$0.00	$0	34,968
2025-06-30	Mayer Jessica L	Chief Legal/Compliance Officer	Other disposed transaction F	Common Shares	5,176	$167.18	$865,324	55,110
2025-03-15	Ramakrishna Sudhakar	Dir	Equity grant / award A	Common Shares	1,049	$0.00	$0	1,049
2025-02-15	Alt Aaron E	Chief Financial Officer	Other disposed transaction F	Common Shares	1,919	$126.21	$242,197	34,948
2024-12-02	WEITZMAN DEBORAH	CEO, PSS Segment	Other disposed transaction F	Common Shares	632	$122.24	$77,256	49,129
2024-11-15	Mayer Jessica L	Chief Legal/Compliance Officer	Other disposed transaction F	Common Shares	5,186	$121.29	$629,010	70,785
2024-11-14	Scherer Mary C.	Chief Accounting Officer	Open-market sell S	Common Shares	3,504	$123.55	$432,919	8,752
2024-11-06	Azelby Robert	Dir	Equity grant / award A	Common Shares	1,730	$0.00	$0	3,018
2024-08-21	Mayer Jessica L	Chief Legal/Compliance Officer	Open-market sell S	Common Shares	16,573	$109.39	$1,812,920	75,971
2024-08-16	Mayer Jessica L	Chief Legal/Compliance Officer	Other disposed transaction F	Common Shares	1,985	$107.91	$214,201	92,544
2024-08-15	Mayer Jessica L	Chief Legal/Compliance Officer	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	5,534	$0.00	$0	0
2024-08-15	Mayer Jessica L	Chief Legal/Compliance Officer	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	3,139	$0.00	$0	0
2024-08-15	Mayer Jessica L	Chief Legal/Compliance Officer	Open-market sell S	Common Shares	17,896	$106.48	$1,905,566	94,529
2024-08-15	Mayer Jessica L	Chief Legal/Compliance Officer	Exercise / conversion M	Common Shares	5,534	$66.43	$367,624	112,425
2024-08-15	Mayer Jessica L	Chief Legal/Compliance Officer	Exercise / conversion M	Common Shares	3,139	$83.91	$263,393	106,891
2024-08-15	Mayer Jessica L	Chief Legal/Compliance Officer	Equity grant / award A	Common Shares	11,491	$0.00	$0	103,752
2024-08-15	Mayer Jessica L	Chief Legal/Compliance Officer	Other disposed transaction F	Common Shares	18,807	$106.36	$2,000,313	92,261
2024-08-13	WEITZMAN DEBORAH	CEO, PSS Segment	Equity grant / award A	Common Shares	13,926	$0.00	$0	48,490
2024-03-15	Greene Michelle D.	Chief Information Officer	Other disposed transaction F	Common Shares	664	$109.93	$72,994	19,486
2024-02-15	Alt Aaron E	Chief Financial Officer	Other disposed transaction F	Common Shares	1,919	$103.55	$198,712	27,400
2023-12-01	Snow Ola M	Chief Human Resources Officer	Other disposed transaction F	Common Shares	382	$107.08	$40,905	24,842
2023-11-27	WEITZMAN DEBORAH	CEO, Pharmaceutical Segment	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	15,373	$0.00	$0	0
2023-11-27	WEITZMAN DEBORAH	CEO, Pharmaceutical Segment	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	6,279	$0.00	$0	0
2023-11-27	WEITZMAN DEBORAH	CEO, Pharmaceutical Segment	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	5,990	$0.00	$0	0
2023-11-27	WEITZMAN DEBORAH	CEO, Pharmaceutical Segment	Open-market sell S	Common Shares	36,642	$106.31	$3,895,411	35,202
2023-11-27	WEITZMAN DEBORAH	CEO, Pharmaceutical Segment	Exercise / conversion M	Common Shares	15,373	$66.43	$1,021,228	71,844
2023-11-27	WEITZMAN DEBORAH	CEO, Pharmaceutical Segment	Exercise / conversion M	Common Shares	6,279	$83.19	$522,350	56,471
2023-11-27	WEITZMAN DEBORAH	CEO, Pharmaceutical Segment	Exercise / conversion M	Common Shares	5,990	$84.27	$504,777	50,192
2023-11-15	Mayer Jessica L	Chief Legal/Compliance Officer	Other disposed transaction F	Common Shares	5,185	$102.90	$533,536	79,680
2023-08-28	WEITZMAN DEBORAH	CEO, Pharmaceutical Segment	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	6,712	$0.00	$0	0
2023-08-28	WEITZMAN DEBORAH	CEO, Pharmaceutical Segment	Open-market sell S	Common Shares	6,712	$89.81	$602,805	44,202
2023-08-28	WEITZMAN DEBORAH	CEO, Pharmaceutical Segment	Exercise / conversion M	Common Shares	6,712	$71.43	$479,438	50,914
2023-08-18	Scherer Mary C.	Chief Accounting Officer	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	3,551	$0.00	$0	0
2023-08-18	Scherer Mary C.	Chief Accounting Officer	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	2,616	$0.00	$0	0
2023-08-18	Scherer Mary C.	Chief Accounting Officer	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	2,496	$0.00	$0	0
2023-08-18	Scherer Mary C.	Chief Accounting Officer	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	2,797	$0.00	$0	0
2023-08-18	Scherer Mary C.	Chief Accounting Officer	Open-market sell S	Common Shares	20,695	$86.27	$1,785,358	10,649
2023-08-18	Scherer Mary C.	Chief Accounting Officer	Exercise / conversion M	Common Shares	3,551	$66.43	$235,893	31,344
2023-08-18	Scherer Mary C.	Chief Accounting Officer	Exercise / conversion M	Common Shares	2,616	$83.19	$217,625	27,793
2023-08-18	Scherer Mary C.	Chief Accounting Officer	Exercise / conversion M	Common Shares	2,496	$84.27	$210,338	25,177
2023-08-18	Scherer Mary C.	Chief Accounting Officer	Exercise / conversion M	Common Shares	2,797	$71.43	$199,790	22,681
2023-08-17	Mayer Jessica L	Chief Legal/Compliance Officer	Open-market sell S	Common Shares	10,668	$87.68	$935,370	84,865
2023-08-16	Mayer Jessica L	Chief Legal/Compliance Officer	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	973	$0.00	$0	0
2023-08-16	Mayer Jessica L	Chief Legal/Compliance Officer	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	1,142	$0.00	$0	0
2023-08-16	Mayer Jessica L	Chief Legal/Compliance Officer	Open-market sell S	Common Shares	30,145	$90.84	$2,738,372	95,533
2023-08-16	Mayer Jessica L	Chief Legal/Compliance Officer	Exercise / conversion M	Common Shares	973	$84.27	$81,995	125,678
2023-08-16	Mayer Jessica L	Chief Legal/Compliance Officer	Exercise / conversion M	Common Shares	1,142	$71.43	$81,573	124,705
2023-08-16	Mayer Jessica L	Chief Legal/Compliance Officer	Equity grant / award A	Common Shares	13,274	$0.00	$0	123,563
2023-08-16	Alt Aaron E	Chief Financial Officer	Equity grant / award A	Common Shares	16,593	$0.00	$0	29,319
2023-08-15	Mayer Jessica L	Chief Legal/Compliance Officer	Other disposed transaction F	Common Shares	20,010	$92.99	$1,860,730	110,289
2023-08-07	Snow Ola M	Chief Human Resources Officer	Equity grant / award A	Common Shares	22,969	$0.00	$0	53,254
2023-08-07	Mayer Jessica L	Chief Legal/Compliance Officer	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	813	$51.49	$41,861	0
2023-08-07	Mayer Jessica L	Chief Legal/Compliance Officer	Other disposed transaction F	Common Shares	618	$91.25	$56,392	130,299
2023-08-07	Mayer Jessica L	Chief Legal/Compliance Officer	Exercise / conversion M	Common Shares	813	$51.49	$41,861	130,917
2023-08-07	Mayer Jessica L	Chief Legal/Compliance Officer	Equity grant / award A	Common Shares	28,329	$0.00	$0	130,104
2023-05-15	Hollar Jason M.	Chief Executive Officer	Other disposed transaction F	Common Shares	3,037	$84.77	$257,446	144,203
2023-03-15	Mayer Jessica L	Chief Legal/Compliance Officer	Other disposed transaction F	Common Shares	1,336	$70.72	$94,482	101,775
2023-02-15	Alt Aaron E	Chief Financial Officer	Equity grant / award A	Common Shares	12,726	$0.00	$0	12,726
2022-12-01	WEITZMAN DEBORAH	CEO, Pharmaceutical Segment	Other disposed transaction F	Common Shares	380	$80.17	$30,465	26,921
2022-11-15	Mayer Jessica L	Chief Legal/Compliance Officer	Other disposed transaction F	Common Shares	5,185	$75.21	$389,964	120,827
2022-11-15	Brennan Michelle	Dir	Open-market buy P	Common Shares	200	$74.72	$14,944	3,324
2022-11-14	Brennan Michelle	Dir	Open-market buy P	Common Shares	200	$76.30	$15,260	3,124
2022-11-09	Chandrasekaran Sujatha	Dir	Equity grant / award A	Common Shares	2,308	$0.00	$0	2,774
2022-11-07	Snow Ola M	Chief Human Resources Officer	Equity grant / award G	Common Shares	630	$0.00	$0	30,557
2022-11-07	Snow Ola M	Chief Human Resources Officer	Open-market sell S	Common Shares	19,590	$78.87	$1,545,063	31,187
2022-10-18	SCARBOROUGH DEAN A	Dir	Equity grant / award A · derivative	Phantom Stock	406	$70.66	$28,688	6,659
2022-09-15	Barg Steven	Dir	Equity grant / award A	Common Shares	466	$0.00	$0	466
2022-08-15	Mason Stephen M	CEO, Medical Segment	Other disposed transaction F	Common Shares	22,579	$69.32	$1,565,176	93,352
2022-08-15	Mason Stephen M	CEO, Medical Segment	Equity grant / award A	Common Shares	17,150	$0.00	$0	115,931
2022-08-09	Mason Stephen M	CEO, Medical Segment	Equity grant / award A	Common Shares	29,893	$0.00	$0	98,781
2022-07-14	SCARBOROUGH DEAN A	Dir	Equity grant / award A · derivative	Phantom Stock	531	$54.05	$28,701	6,280
2022-06-28	Kaufmann Michael C	CEO	Other disposed transaction F	Common Shares	9,523	$54.86	$522,432	540,131
2022-05-15	Hollar Jason M.	Chief Financial Officer	Other disposed transaction F	Common Shares	3,392	$55.61	$188,629	52,125
2022-04-14	SCARBOROUGH DEAN A	Dir	Equity grant / award A · derivative	Phantom Stock	456	$62.96	$28,710	5,736
2022-03-15	Mayer Jessica L	Chief Legal/Compliance Officer	Other disposed transaction F	Common Shares	1,332	$52.61	$70,077	104,811
2022-02-15	Rice Brian S	Chief Information Officer	Other disposed transaction F	Common Shares	1,960	$52.29	$102,488	34,414
2022-01-18	Snow Ola M	Chief Human Resources Officer	Open-market buy P	Common Shares	112	$53.12	$5,949	30,285
2022-01-13	SCARBOROUGH DEAN A	Dir	Equity grant / award A · derivative	Phantom Stock	550	$52.24	$28,732	5,309
2021-12-01	Kaufmann Michael C	CEO	Other disposed transaction F	Common Shares	2,798	$46.23	$129,352	549,654
2021-11-18	Snow Ola M	Chief Human Resources Officer	Open-market sell S	Common Shares	10,000	$49.17	$491,700	36,969
2021-11-15	Mayer Jessica L	Chief Legal/Compliance Officer	Equity grant / award A	Common Shares	34,681	$0.00	$0	106,143
2021-11-11	Killefer Nancy	Dir	Equity grant / award A	Common Shares	3,709	$0.00	$0	20,554
2021-10-15	Snow Ola M	Chief Human Resources Officer	Open-market buy P	Common Shares	212	$48.88	$10,363	30,173
2021-08-15	Holcomb Michele	EVP - Strategy & Corp. Dev.	Other disposed transaction F	Common Shares	7,739	$51.70	$400,106	40,892
2021-08-15	Holcomb Michele	EVP - Strategy & Corp. Dev.	Equity grant / award A	Common Shares	8,511	$0.00	$0	48,631
2021-08-12	Kaufmann Michael C	CEO	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	76,909	$0.00	$0	0
2021-08-12	Kaufmann Michael C	CEO	Other disposed transaction F	Common Shares	68,631	$51.69	$3,547,536	544,711
2021-08-12	Kaufmann Michael C	CEO	Exercise / conversion M	Common Shares	76,909	$41.60	$3,199,414	613,342
2021-08-03	Rice Brian S	Chief Information Officer	Equity grant / award A	Common Shares	8,291	$0.00	$0	34,225
2021-07-15	LOSH J MICHAEL	Dir	Equity grant / award A · derivative	Phantom Stock	506	$56.77	$28,726	6,567
2021-06-28	Kaufmann Michael C	CEO	Other disposed transaction F	Common Shares	6,962	$57.28	$398,783	437,567
2021-05-15	Hollar Jason M.	Chief Financial Officer	Other disposed transaction F	Common Shares	2,033	$56.34	$114,539	37,025
2021-04-15	LOSH J MICHAEL	Dir	Equity grant / award A · derivative	Phantom Stock	472	$60.82	$28,707	5,966
2021-03-15	Mayer Jessica L	Chief Legal/Compliance Officer	Other disposed transaction F	Common Shares	911	$57.35	$52,246	11,705
2021-03-15	Mayer Jessica L	Chief Legal/Compliance Officer	Other disposed transaction F	Common Shares	911	$57.35	$52,246	48,166
2021-02-26	Mayer Jessica L	Chief Legal/Compliance Officer	Open-market sell S	Common Shares	3,500	$51.53	$180,355	12,616
2021-02-15	Rice Brian S	Chief Information Officer	Other disposed transaction F	Common Shares	1,353	$51.86	$70,167	25,934
2021-02-11	English Patricia M	Chief Accounting Officer	Open-market sell S	Common Shares	3,291	$51.98	$171,066	6,085
2021-01-15	SCARBOROUGH DEAN A	Dir	Equity grant / award A · derivative	Phantom Stock	519	$55.39	$28,747	2,918
2020-12-01	Kaufmann Michael C	CEO	Other disposed transaction F	Common Shares	3,206	$54.59	$175,016	444,529
2020-11-15	CRAWFORD VICTOR L.	CEO, Pharmaceutical Segment	Other disposed transaction F	Common Shares	4,362	$57.43	$250,510	61,124
2020-11-09	JOHRI AKHIL	Dir	Equity grant / award A	Common Shares	3,339	$0.00	$0	12,089
2020-11-08	Kaufmann Michael C	CEO	Other disposed transaction F	Common Shares	6,485	$52.64	$341,370	447,735
2020-10-15	Snow Ola M	Chief Human Resources Officer	Other disposed transaction F	Common Shares	593	$48.37	$28,683	36,889
2020-09-15	Edison Sheri H.	Dir	Equity grant / award A	Common Shares	730	$0.00	$0	730
2020-08-15	Snow Ola M	Chief Human Resources Officer	Other disposed transaction F	Common Shares	1,911	$53.68	$102,582	37,482
2020-08-15	Snow Ola M	Chief Human Resources Officer	Equity grant / award A	Common Shares	11,177	$0.00	$0	39,393
2020-08-03	Snow Ola M	Chief Human Resources Officer	Equity grant / award A	Common Shares	238	$0.00	$0	28,216
2020-07-15	Evans David C	Dir	Equity grant / award A	Common Shares	1,255	$0.00	$0	1,255
2020-06-28	Kaufmann Michael C	CEO	Other disposed transaction F	Common Shares	6,649	$50.55	$336,107	403,762
2020-04-15	SCARBOROUGH DEAN A	Dir	Equity grant / award A · derivative	Phantom Stock	567	$50.69	$28,741	1,564
2020-03-15	Mayer Jessica L	Chief Legal/Compliance Officer	Other disposed transaction F	Common Shares	916	$47.62	$43,620	48,009
2020-02-15	Rice Brian S	Chief Information Officer	Other disposed transaction F	Common Shares	1,334	$59.62	$79,533	20,807
2020-01-16	Holcomb Michele	EVP - Strategy & Corp. Dev.	Other disposed transaction F	Common Shares	971	$53.81	$52,250	24,810
2020-01-15	SCARBOROUGH DEAN A	Dir	Equity grant / award A · derivative	Phantom Stock	529	$52.45	$27,746	653
2019-12-02	LAWS STUART G	SVP & Chief Accounting Officer	Other disposed transaction F	Common Shares	75	$55.03	$4,127	12,962
2019-11-15	CRAWFORD VICTOR L.	CEO, Pharmaceutical Segment	Other disposed transaction F	Common Shares	4,144	$54.75	$226,884	48,074
2019-11-12	LOSH J MICHAEL	Dir	Equity grant / award A	Common Shares	3,424	$0.00	$0	6,649
2019-11-08	Kaufmann Michael C	CEO	Other disposed transaction F	Common Shares	6,638	$53.20	$353,142	412,898
2019-10-15	Snow Ola M	Chief Human Resources Officer	Other disposed transaction F	Common Shares	491	$46.78	$22,969	27,978
2019-09-15	WEILAND JOHN H	Dir	Equity grant / award A	Common Shares	666	$0.00	$0	666
2019-08-15	LAWS STUART G	SVP & Chief Accounting Officer	Other disposed transaction F	Common Shares	1,048	$42.41	$44,446	13,037
2019-08-15	LAWS STUART G	SVP & Chief Accounting Officer	Equity grant / award A	Common Shares	5,952	$0.00	$0	14,085
2019-08-06	Snow Ola M	Chief Human Resources Officer	Equity grant / award A	Common Shares	3,329	$0.00	$0	18,315
2019-07-15	LOSH J MICHAEL	Dir	Equity grant / award A · derivative	Phantom Stock	682	$47.59	$32,456	1,579
2019-06-28	Kaufmann Michael C	Chief Executive Officer	Equity grant / award A	Common Shares	63,694	$0.00	$0	334,958
2019-04-15	LOSH J MICHAEL	Dir	Equity grant / award A · derivative	Phantom Stock	694	$46.79	$32,472	896
2019-02-15	Rice Brian S	Chief Information Officer	Equity grant / award A	Common Shares	12,617	$0.00	$0	12,617
2019-01-16	Holcomb Michele	EVP - Strategy & Corp. Dev.	Other disposed transaction F	Common Shares	983	$47.63	$46,820	17,356
2019-01-15	DARDEN CALVIN	Dir	Equity grant / award A · derivative	Phantom Stock	119	$47.28	$5,626	6,222
2018-12-15	LOSH J MICHAEL	Dir	Equity grant / award A	Common Shares	3,225	$0.00	$0	3,225
2018-12-03	Kaufmann Michael C	Chief Executive Officer	Other disposed transaction F	Common Shares	1,636	$54.83	$89,702	271,264
2018-11-15	Morford Craig S	Chief Legal/Compliance Officer	Other disposed transaction F	Common Shares	274	$57.31	$15,703	126,618
2018-11-13	LAWS STUART G	SVP & Chief Accounting Officer	Open-market sell S	Common Shares	46	$56.05	$2,578	6,296
2018-11-12	LAWS STUART G	SVP & Chief Accounting Officer	Open-market sell S	Common Shares	758	$55.52	$42,084	6,342
2018-11-09	Killefer Nancy	Dir	Equity grant / award A	Common Shares	3,164	$0.00	$0	10,082
2018-11-08	Kaufmann Michael C	Chief Executive Officer	Other disposed transaction F	Common Shares	7,354	$53.65	$394,542	272,900
2018-10-15	DARDEN CALVIN	Dir	Equity grant / award A · derivative	Phantom Stock	106	$51.63	$5,473	6,091
2018-08-31	MORRISON PATRICIA	Chief Information Officer	Other disposed transaction F	Common Shares	2,719	$52.45	$142,612	30,725
2018-08-20	Giacomin Jon L	CEO, Medical Segment	Open-market sell S	Common Shares	2,890	$51.95	$150,136	72,652
2018-08-15	Giacomin Jon L	CEO, Medical Segment	Other disposed transaction F	Common Shares	3,387	$50.17	$169,926	75,542
2018-08-15	Giacomin Jon L	CEO, Medical Segment	Equity grant / award A	Common Shares	23,881	$0.00	$0	78,929
2018-08-09	DARDEN CALVIN	Dir	Equity grant / award A · derivative	Phantom Stock	14	$48.96	$685	5,985
2018-07-16	DARDEN CALVIN	Dir	Equity grant / award A · derivative	Phantom Stock	98	$50.80	$4,978	5,973
2018-06-30	Kimmet Pamela O.	Chief Human Resources Officer	Other disposed transaction F	Common Shares	383	$48.83	$18,702	13,343
2018-05-15	Gomez Jorge M	Chief Financial Officer	Other disposed transaction F	Common Shares	167	$55.16	$9,212	21,911
2018-04-16	DARDEN CALVIN	Dir	Equity grant / award A · derivative	Phantom Stock	82	$60.42	$4,954	5,859
2018-02-20	Giacomin Jon L	CEO, Medical Segment	Open-market sell S	Common Shares	2,271	$69.12	$156,972	55,048
2018-02-20	Giacomin Jon L	CEO, Medical Segment	Open-market sell S	Common Shares	5,724	$68.65	$392,953	57,319
2018-02-15	MORRISON PATRICIA	Chief Information Officer	Other disposed transaction F	Common Shares	1,179	$67.34	$79,394	34,978
2018-02-15	Giacomin Jon L	CEO, Medical Segment	Equity grant / award A	Common Shares	14,684	$0.00	$0	63,043
2018-02-14	MORRISON PATRICIA	Chief Information Officer	Open-market sell S	Common Shares	28,532	$66.30	$1,891,672	36,157
2018-01-22	Kaufmann Michael C	Chief Executive Officer	Open-market sell S	Common Shares	18,586	$73.90	$1,373,505	211,849
2018-01-16	DARDEN CALVIN	Dir	Equity grant / award A · derivative	Phantom Stock	69	$71.49	$4,933	5,760
2017-12-01	Kaufmann Michael C	CFO	Other disposed transaction F	Common Shares	551	$59.19	$32,614	230,435
2017-11-15	Morford Craig S	Chief Legal/Compliance Officer	Other disposed transaction F	Common Shares	285	$57.07	$16,265	109,873
2017-11-08	Kaufmann Michael C	CFO	Equity grant / award A	Common Shares	49,188	$0.00	$0	230,986
2017-10-16	DARDEN CALVIN	Dir	Equity grant / award A · derivative	Phantom Stock	76	$64.96	$4,937	5,690
2017-09-15	Kaufmann Michael C	CFO	Other disposed transaction F	Common Shares	6,331	$67.46	$427,089	181,798
2017-08-15	Kaufmann Michael C	CFO	Equity grant / award A · derivative	Employee Stock Option (right to buy)	70,102	$0.00	$0	70,102
2017-08-15	Kaufmann Michael C	CFO	Other disposed transaction F	Common Shares	9,304	$66.76	$621,135	188,129
2017-08-15	Kaufmann Michael C	CFO	Equity grant / award A	Common Shares	14,301	$0.00	$0	197,433
2017-08-08	Casey Donald M Jr.	CEO, Medical Segment	Equity grant / award A	Common Shares	13,034	$0.00	$0	143,235
2017-07-17	ANDERSON DAVID J	Dir	Equity grant / award A · derivative	Phantom Stock	32	$78.11	$2,500	62
2017-06-30	Kimmet Pamela O.	Chief Human Resources Officer	Other disposed transaction F	Common Shares	422	$78.25	$33,022	8,232
2017-05-12	Giacomin Jon L	CEO, Pharmaceutical Segment	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	23,270	$41.60	$968,032	0
2017-05-12	Giacomin Jon L	CEO, Pharmaceutical Segment	Open-market sell S	Common Shares	23,270	$72.87	$1,695,685	32,170
2017-05-12	Giacomin Jon L	CEO, Pharmaceutical Segment	Exercise / conversion M	Common Shares	23,270	$41.60	$968,032	55,440
2017-05-08	JONES CLAYTON M	Dir	Other disposed transaction D	Common Shares	502	$71.99	$36,139	0
2017-05-08	JONES CLAYTON M	Dir	Open-market sell S	Common Shares	502	$71.99	$36,139	0
2017-04-17	DARDEN CALVIN	Dir	Equity grant / award A · derivative	Phantom Stock	61	$81.43	$4,967	5,526
2017-02-10	Barrett George S	Chairman and CEO	Open-market sell S	Common Shares	217,994	$77.23	$16,835,677	464,231
2017-02-10	Barrett George S	Chairman and CEO	Exercise / conversion M · derivative	Common Shares	217,994	$0.00	$0	0
2017-01-16	DARDEN CALVIN	Dir	Equity grant / award A · derivative	Phantom Stock	66	$75.00	$4,950	5,470
2016-11-10	Barrett George S	Chairman and CEO	Open-market sell S	Common Shares	6,600	$71.82	$474,012	464,231
2016-11-10	Barrett George S	Chairman and CEO	Open-market sell S	Common Shares	194,441	$71.35	$13,873,365	470,831
2016-11-10	Barrett George S	Chairman and CEO	Open-market sell S	Common Shares	16,954	$70.40	$1,193,562	665,272
2016-11-10	Barrett George S	Chairman and CEO	Exercise / conversion M · derivative	Common Shares	217,995	$0.00	$0	217,994
2016-11-03	KENNY GREGORY B	Dir	Equity grant / award A	Common Shares	2,753	$0.00	$0	26,697
2016-10-17	DARDEN CALVIN	Dir	Equity grant / award A · derivative	Phantom Stock	66	$75.27	$4,968	5,404
2016-09-15	Kaufmann Michael C	CFO	Other disposed transaction F	Common Shares	6,330	$75.26	$476,396	173,598
2016-08-18	LAWS STUART G	SVP & Chief Accounting Officer	Open-market sell S	Common Shares	9,703	$82.45	$800,012	2,718
2016-08-15	LAWS STUART G	SVP & Chief Accounting Officer	Equity grant / award A · derivative	Employee Stock Option (right to buy)	4,984	$0.00	$0	4,985
2016-08-15	LAWS STUART G	SVP & Chief Accounting Officer	Other disposed transaction F	Common Shares	1,316	$83.60	$110,018	12,421
2016-08-15	LAWS STUART G	SVP & Chief Accounting Officer	Equity grant / award A	Common Shares	1,002	$0.00	$0	13,737
2016-08-11	Morford Craig S	Chief Legal/Compliance Officer	Open-market sell S	Common Shares	12,697	$83.13	$1,055,502	90,811
2016-08-10	Barrett George S	Chairman and CEO	Open-market sell S	Common Shares	99,754	$83.44	$8,323,474	490,334
2016-08-10	Barrett George S	Chairman and CEO	Exercise / conversion M · derivative	Common Shares	99,754	$0.00	$0	435,989
2016-08-10	Casey Donald M Jr.	CEO, Medical Segment	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	32,696	$0.00	$0	0
2016-08-10	Casey Donald M Jr.	CEO, Medical Segment	Open-market sell S	Common Shares	32,696	$83.42	$2,727,500	138,319
2016-08-10	Casey Donald M Jr.	CEO, Medical Segment	Exercise / conversion M	Common Shares	32,696	$40.58	$1,326,804	171,015
2016-08-09	Barrett George S	Chairman and CEO	Open-market sell S	Common Shares	129,818	$83.76	$10,873,556	490,334
2016-08-09	Barrett George S	Chairman and CEO	Exercise / conversion M · derivative	Common Shares	129,818	$0.00	$0	535,743
2016-08-09	Casey Donald M Jr.	CEO, Medical Segment	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	26,484	$0.00	$0	32,696
2016-08-09	Casey Donald M Jr.	CEO, Medical Segment	Open-market sell S	Common Shares	26,484	$83.81	$2,219,624	138,319
2016-08-09	Casey Donald M Jr.	CEO, Medical Segment	Exercise / conversion M	Common Shares	26,484	$40.58	$1,074,721	164,803
2016-08-08	Barrett George S	Chairman and CEO	Open-market sell S	Common Shares	20,428	$83.75	$1,710,845	490,334
2016-08-08	Barrett George S	Chairman and CEO	Exercise / conversion M · derivative	Common Shares	20,428	$0.00	$0	665,561
2016-08-04	Morford Craig S	Chief Legal/Compliance Officer	Equity grant / award A	Common Shares	13,206	$0.00	$0	103,508
2016-07-15	DARDEN CALVIN	Dir	Equity grant / award A · derivative	Phantom Stock	60	$82.97	$4,978	5,297
2016-06-30	Kimmet Pamela O.	Chief Human Resources Officer	Equity grant / award A	Common Shares	3,846	$0.00	$0	3,846
2016-05-20	WATKINS CAROLE S	Chief HR Officer	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	84,617	$0.00	$0	0
2016-05-20	WATKINS CAROLE S	Chief HR Officer	Open-market sell S	Common Shares	84,617	$77.33	$6,543,433	31,585
2016-05-20	WATKINS CAROLE S	Chief HR Officer	Exercise / conversion M	Common Shares	84,617	$27.29	$2,309,198	116,202
2016-04-15	DARDEN CALVIN	Dir	Equity grant / award A · derivative	Phantom Stock	59	$83.91	$4,951	5,249

Regulatory Activity

Last 12 months to 2025-04-29

Insider Filings (Forms 3/4/5) — 12 months

Material Event Filings (8-K) — 12 months

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count